Corteva has completed the spin-off of its advanced seed and genetics business to become a pure-play global crop protection company. The move allows Corteva to focus on its strong crop protection segment, which grew revenue by over $1 billion from 2020 to 2025 and expanded margins. With a robust $11 billion pipeline including 12 new actives and 5 biologicals planned for launch in the next decade, Corteva aims to lead innovation in sustainable crop protection solutions worldwide. The company serves growers in about 110 countries and emphasizes operational excellence and customer focus going forward.
Corteva's new chapter as a focused crop protection leader is the subject here. For readers following the broader market, 87 of 150 US stocks on Pluang rose while 55 fell. Notable movers include SNAP at USD 5.47 with a 1.48% increase and HPE at USD 64.77 with a 1.38% increase, as of Oct 01, 2026 18:14 WIB.
An analyst at Truist Financial raised Wells Fargo's price target to $95, suggesting a 20.74% upside from its current price. This optimism is driven by expected strong third-quarter earnings of $1.85 per share and $22.34 billion in revenue, surpassing...
Oklo is developing advanced fast-fission reactors to power future data centers and industrial hubs, aiming to lead in carbon-free energy. Piper Sandler reaffirmed an "Overweight" rating on the stock, reflecting confidence in Oklo's growth prospects. ...
Nike is set to release its quarterly earnings on October 1, 2026, with analysts forecasting an EPS of $0.44 and revenue of $11.32 billion, both down from last year. The company's stock has fallen 80% this year, hitting 13-year lows, reflecting a chal...
Lamb Weston is set to report Q3 earnings with analysts forecasting an EPS of $0.59, down from $0.74 last year, and revenue around $1.65 billion, nearly flat compared to the prior year. The company’s "Focus to Win" strategy has generated over $100 mil...
Cal-Maine Foods reported a $58.6 million net loss and a 42% drop in net sales, driven by lower conventional egg prices. An analyst downgraded the stock to Hold with a $70 price target, reflecting a modest 2.85% upside from current levels. Despite cha...
